Community Guide Program, Office of Scientific Evidence and Recommendations, Office of Science, Centers for Disease Control and Prevention, Atlanta, Georgia.
Community Guide Program, Office of Scientific Evidence and Recommendations, Office of Science, Centers for Disease Control and Prevention, Atlanta, Georgia.
Am J Prev Med. 2024 Jun;66(6):1089-1099. doi: 10.1016/j.amepre.2024.01.021. Epub 2024 Feb 6.
This systematic economic review examined the cost-benefit and cost-effectiveness of park, trail, and greenway infrastructure interventions to increase physical activity or infrastructure use.
The search period covered the date of inception of publications databases through February 2022. Inclusion was limited to studies that reported cost-benefit or cost-effectiveness outcomes and were based in the U.S. and other high-income countries. Analyses were conducted from March 2022 through December 2022. All monetary values reported are in 2021 U.S. dollars.
The search yielded 1 study based in the U.S. and 7 based in other high-income countries, with 1 reporting cost-effectiveness and 7 reporting cost-benefit outcomes. The cost-effectiveness study based in the United Kingdom reported $23,254 per disability-adjusted life year averted. The median benefit-to-cost ratio was 3.1 (interquartile interval=2.9-3.9) on the basis of 7 studies.
The evidence shows that economic benefits exceed the intervention cost of park, trail, and greenway infrastructure. Given large differences in the size of infrastructure, intervention costs and economic benefits varied substantially across studies. There was insufficient number of studies to determine the cost-effectiveness of these interventions.
本系统经济学评价考察了公园、步道和绿道基础设施干预措施在提高身体活动或基础设施使用方面的成本效益和成本效果。
检索期涵盖了出版物数据库成立日期至 2022 年 2 月。纳入研究限于报告成本效益或成本效果结果且基于美国和其他高收入国家的研究。分析于 2022 年 3 月至 2022 年 12 月进行。所有报告的货币价值均为 2021 年美元。
检索结果包括 1 项基于美国的研究和 7 项基于其他高收入国家的研究,其中 1 项报告了成本效果,7 项报告了成本效益结果。基于英国的成本效果研究报告称,每避免一个残疾调整生命年的成本为 23254 美元。基于 7 项研究,效益成本比的中位数为 3.1(四分位间距=2.9-3.9)。
证据表明,经济效益超过了公园、步道和绿道基础设施的干预成本。鉴于基础设施规模存在较大差异,干预成本和经济效益在不同研究中差异很大。由于研究数量不足,无法确定这些干预措施的成本效果。